Anzeige
Mehr »
Login
Montag, 29.04.2024 Börsentäglich über 12.000 News von 686 internationalen Medien
Basin Uranium: Es geht los! Der Uran-Superzyklus ist gestartet!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
64 Leser
Artikel bewerten:
(0)

Global Electroencephalography Devices Market to Grow at a CAGR of 9.5% by 2021: Analysis By Product, Technology & End Users

DUBLIN, August 16, 2017 /PRNewswire/ --

The "Global Electroencephalography Devices Market 2017-2021" report has been added to Research and Markets' offering.

Research and Markets Logo

The global electroencephalography devices market to grow at a CAGR of 9.54% during the period 2017-2021.

The report, Global Electroencephalography Devices Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

One trend in the market is increasing focus on digitized EEG devices. The cognitive ability of an individual is extremely important to perform the day-to-day activity. In recent years, there has been increased awareness regarding brain health and is considered as an important healthcare area that requires immediate medical support in case of any brain dysfunction such as mental illness, sleep disorder, and neurological disorder.

According to the report, one driver in the market is growing demand for EEG. EEG devices are the common diagnostic devices for medical conditions such as epilepsy, TBI, Alzheimer's disease, and dementia. The increasing prevalence of these diseases raises the demand for EEG devices in various healthcare centers such as hospitals, ASCs, neurological centers, clinics, and diagnostic laboratories. EEG device is one of the prominent diagnostic instrument to measure brain dysfunction and plays a significant role in monitoring and diagnosing individuals suffering from seizure disorders like epilepsy.

Further, the report states that one challenge in the market is high cost of neurodiagnostic procedures. The incidence of various neurological diseases is on rising hence, the use of EEG device has increased subsequently over the years. However, for complex medical conditions, the need for sophisticated and technologically advanced EEG device demand high-cost medical procedures that increase the overall economic burden on the individual and caretaker. Usually, EEG test costs approximately $200-$700. However, the cost may rise to $3,000 in an individual with complex medical complications and who require extended monitoring suggested by the physician.

Key vendors

  • Advanced Brain Monitoring
  • Compumedics
  • Natus Medical
  • Nihon Kohden

Other prominent vendors

  • Allengers
  • Bio-Signal Group
  • BrainScope
  • Cadwell Industries
  • Clinical Science Systems
  • DePuy Synthes
  • Deymed Diagnostic
  • EB Neuro
  • Others

Key Topics Covered:

Part 01: Executive Summary

Part 02: Scope Of The Report

Part 03: Research Methodology

Part 04: Introduction

Part 05: Market Landscape

Part 06: Market Segmentation By Product

Part 07: Market Segmentation By Technology

Part 08: Market Segmentation By End-Users

Part 09: Geographical Segmentation

Part 09: Decision Framework

Part 10: Drivers And Challenges

Part 11: Market Trends

Part 12: Vendor Landscape

Part 13: Key Vendor Analysis

Part 14: Appendix

For more information about this report visit https://www.researchandmarkets.com/research/cbjcnq/global

Media Contact:

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Großer Insider-Report 2024 von Dr. Dennis Riedl
Wenn Insider handeln, sollten Sie aufmerksam werden. In diesem kostenlosen Report erfahren Sie, welche Aktien Sie im Moment im Blick behalten und von welchen Sie lieber die Finger lassen sollten.
Hier klicken
© 2017 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.